PT  - JOURNAL ARTICLE
AU  - Toktam, Kianifard
AU  - Manjit, Saluja
AU  - Sanjeev, Sarmukaddam
AU  - Anuradha, Venugopalan
AU  - Arvind, Chopra
TI  - An Adjunct Role Of Potassium Rich Vegetarian Diet And A Novel Potassium Food Supplement To Improve Pain In Chronic Rheumatoid Arthritis On Supervised Standard Care: A Randomized Controlled Study
AID  - 10.1101/2022.06.24.22276843
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2022.06.24.22276843
4099  - http://medrxiv.org/content/early/2023/04/10/2022.06.24.22276843.short
4100  - http://medrxiv.org/content/early/2023/04/10/2022.06.24.22276843.full
AB  - Introduction Potassium inadequacy (diet and body storage) may adversely affect rheumatoid arthritis (RA) and is sparsely reported. We evaluated the therapeutic benefits (RA) of food-based potassium intake, recommended daily allowance (RDA), and higher.Objective To evaluate pain reduction by oral potassium in chronic RAMethods 172 consenting and eligible symptomatic patients (median duration 6.5 years) on ongoing standard care were randomized in a single-center study (80% power, significant p < 0.05) - Arm A (vegetarian diet as per the India RDA for potassium), Arm B (Arm A diet plus novel potassium food supplement) and Arm C (regular diet, control). Efficacy and safety, and diet intake (three-day recall, Food Composition tables) were assessed (blinded) at monthly intervals till 16-week of study completion and statistically analyzed using standard methods. Study groups were found matched and showed inadequate baseline dietary potassium (RDA). On study completion, the median daily potassium intake was 2959 mg in Arm A, 6063 mg in Arm B, and 2553 mg in Arm C. Study subjects remained normokalemic at all evaluations. Overall, the background medication remained stable.Results 155 patients (90.1%) completed the study. Adverse events were mild. On comparison, the improvement in pain (primary efficacy) on study completion was significant in Arm B as per protocol analysis; the mean change in pain visual analog scale from baseline was −2.23 (95% confidence interval −2.99 to −1.48). Arm B showed impressive improvement in joint function. High potassium intake predicted low pain (Likelihood ratio 2.9, logistic regression). Compliance (intervention), diet recall, medication, complex nature of dietary intervention/other nutrients, and lack of placebo were potential confounders to ascertain the effectiveness of potassium.Conclusion A planned vegetarian diet and food supplement intervention with a predominantly increased potassium intake significantly reduced chronic RA pain. This adjunct treatment was found safe and well tolerated. However, it requires further validation.Trial Registration Clinical Trial Registry of India- CTRI/2022/03/040726What is already known on the topic?RA is predominantly managed with drug therapy and diet is often neglectedRA is complicated by hypertension and other cardiovascular disorders, and osteoporosis which may benefit from potassium intervention.Potassium and potassium ion channels are important the pathophysiology of pain (and probably inflammation)Patients of RA may be deficient in potassium due to inadequate diet or sarcopeniaWhat does this study add?Potassium-rich vegetarian diet and a novel high-potassium food supplement significantly reduced pain in chronic RA on supervised standard drug care.Several participants showed improved joint function and better blood pressure statusHigher potassium intake based on food and diet was safe and well toleratedHow this study might affect research, practice, or policy?Potassium rich predominantly vegetarian diet should be advocated in the management of RA as an adjuvantA judicious use of high potassium food supplement along with suitable diet may benefit difficult and chronic RAThe current guidelines on oral potassium intake in RA and other medical disorders need to be revised and call for more researchCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialCTRI/2022/03/040726Funding StatementThis study did not receive any funding from any external or commercial source. Non-commercial investigator initiated study and partly funded by Arthritis Research Care Foundation - Center for Rheumatic Diseases, Pune, India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics Committee, Arthritis Research Care Foundation Center for Rheumatic Diseases, Pune, India. The approval letter dated 04 Feb 2014 is enclosed as a supporting documentI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors